Skip to content
Fencer Intel
high 7.8

CVE-2015-3958 json

Hospira LifeCare PCA Infusion System 5.0 and earlier, and possibly other versions, allows remote attackers to cause a denial of service (fo…

published 2015-07-06 11 y ago modified 2026-06-17 4 mo ago also EUVD-2015-3989

cvss
7.8
version 2.0, NVD
cisa kev
Not listed
not in CISA's catalog
epss
2.6%
EPSS 2.6% chance of exploitation in 30 days, percentile 85%
public exploits
0
none known

Summary

Hospira LifeCare PCA Infusion System 5.0 and earlier, and possibly other versions, allows remote attackers to cause a denial of service (forced manual reboot) via a flood of TCP packets.

Vendor advisories

What the vendors themselves say about their products: affected, fixed or not affected, and what to do.

cisa ICSA-15-161-01 updated cvss 7.8

Hospira Plum A+ and Symbiq Infusion Systems Vulnerabilities

  • Hospira Plum A+ Infusion System <=13.4 Hospira Plum A+3 Infusion System <=13.6 Hospira Symbiq Infusion System,As previously announced by Hospira in 2013, the Symbiq Infusion System was retired by Hospira on May 31, 2015 and will be fully removed from the market by December 2015. Accordi <=3.13
    affected: mitigation “For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.”

From CISA ICS and IT advisories (CSAF, https://github.com/cisagov/CSAF), a U.S. Government work; changed: reduced to products, statuses and remediations. CISA notification · csaf

cisa ICSA-15-125-01B updated cvss 7.8

Hospira LifeCare PCA Infusion System Vulnerabilities

  • Hospira LifeCare PCA Infusion System <=5.0
    affected: mitigation “For additional information about Hospira’s upcoming release, contact Hospira’s technical support at 1-800-241-4002.”

From CISA ICS and IT advisories (CSAF, https://github.com/cisagov/CSAF), a U.S. Government work; changed: reduced to products, statuses and remediations. CISA notification · csaf

Exploit prediction

2.56% chance of exploitation in the next 30 days, higher than 85% of all scored CVEs (FIRST EPSS, 2026-11-09).

CVSS scores

assigned by version score vector
NVD 2.0 7.8 AV:N/AC:L/Au:N/C:N/I:N/A:C

Classification

Weakness
  • CWE-19 Data Processing Errors

References

Sources

Fencer Intel keeps one entry per vulnerability: the CVE id wins, then GHSA, and records that alias each other are merged, except that two CVEs always keep separate entries. The same data is available as JSON.